Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda PharmaceuticalsReminds Vanda’s Board of Their Fiduciary Duties Given the Mishandling of Future Pak’s Offer to Acquire Vanda’s Underperforming and Undervalued Shares at an ~80-90% Premium
